EC-T regimen: epirubicin 90mg/m2 day1, CTX 600mg/m2, day 1, 21 days per cycle \*4cycle. followed by paclitaxel 175mg/m2,d1,21days per cycle, 4 cycle.
ET regimen: epirubicin 75mg/m2 day1,paclitaxel 175mg/m2,d2,21days per cycle, 6 cycle
Age
18–70
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
patients with breast cancer after breast cancer surgery with positive lymph nodes age 18-70 years old
You may not be if
with other malignance disease
Clareo Health | Regimens Comparison for Breast Cancers of Positive Lymph Nodes
